Use of a vesicular stomatitis virus complementation system to analyze respiratory syncytial virus binding

Virus Research

Volumn 90, Issue 1-2, 2002, Pages 327-335

  Klenk, Kaci ^a,b   Roberts, Sharon R ^a  

^a AUBURN UNIVERSITY   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

Glycosaminoglycan; Respiratory syncytial virus; Virus complementation; VSV G*

Indexed keywords

GLYCOSAMINOGLYCAN; RESPIRATORY SYNCTIAL VIRUS G PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SULFATION; VESICULAR STOMATITIS VIRUS; VIRION; VIRUS ADSORPTION; VIRUS CELL INTERACTION; VIRUS RECOMBINANT;

ANIMALS; CELL LINE; CRICETINAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE DELETION; GENETIC COMPLEMENTATION TEST; HUMANS; MEMBRANE GLYCOPROTEINS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; VESICULAR STOMATITIS-INDIANA VIRUS; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 0036891626     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(02)00250-2     Document Type: Article

References (31)

1. Bächi T. Direct observation of the budding and fusion of an enveloped virus by video microscopy of viable cells. J. Cell Biol. 107:1988;1689-1695.
2. Bukreyev A., Whitehead S.S., Murphy B.R., Collins P.L. Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse. J. Virol. 71:1997;8973-8982.
3. Collins P.L., Huang Y.T., Wertz G.W. Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus. Proc. Natl. Acad. Sci. USA. 81:1984;7683-7687.
4. Collins P.L., Hill M.G., Camargo E., Grosfeld H., Chanock R.M., Murphy B.R. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA and provides a capability for vaccine development. Proc. Natl. Acad. Sci. USA. 92:1995;11563-11567.
5. Collins P.L., McIntosh K., Chanock R.M. Respiratory syncytial virus. Fields B.N., Knipe D.M., Howley P.M. Fields Virology. 1996;1313-1351 Lippencott-Raven, Philadelphia, PA.
6. Downing L.A., Bernstein J.M., Walter A. Active respiratory syncytial virus purified by ion-exchange chromatography: characterization of binding and elution requirements. J. Virol. Meth. 38:1992;215-228.
7. Hallak L.K., Collins P.L., Knudson W., Peeples M.E. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection. Virology. 271:2000;264-275.
8. Hallak L.K., Spillmann D., Collins P.L., Peeples M.E. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J. Virol. 74:2000;10508-10513.
9. Hendricks D.A., Baradaran A.K., McIntosh K., Patterson J.L. Appearance of a soluble form of the G protein of respiratory syncytial virus in fluids of infected cells. J. Gen. Virol. 68:1987;1705-1714.
10. Hendricks D.A., McIntosh K., Patterson J.L. Further characterization of the soluble form of the G protein of respiratory syncytial virus. J. Virol. 62:1988;2228-2233.
11. Kahn J.S., Schnell M.J., Buonocore L., Rose J.K. Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion. Virology. 254:1999;81-91.
12. Karron R.A., Buonagurio D.A., Georgiu A.F., Whitehead S.S., Adamus J.E., Clements-Mann M.L., Harris D.O., Randolph V.B., Udem S.A., Murphy B.R., Sidhu M. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged attenuated RSV subgroup B mutant. Proc. Natl. Acad. Sci. USA. 94:1997;13961-13966.
13. Kretzchmar E., Buonocore L., Schnell M.J., Rose J.K. High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses. J. Virol. 71:1997;5982-5989.
14. Krusat T., Streckert H.J. Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells. Arch. Virol. 142:1997;1247-1254.
15. Lamb R.A., Kolakofsky D. Paramyxoviridae: the viruses and their replication. Fields B.N., Knipe D.M., Howley P.M. Fundamental Virology. 1996;577-604 Lippincott-Raven, Philadelphia, PA.
16. Levine S., Klaiber-Franco R., Paradiso P.R. Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus. J. Gen. Virol. 68:1987;2521-2524.
17. Mbiguino A., Menezes J. Purification of human respiratory syncytial virus: superiority of sucrose gradient over percoll, renografin, and metrizamide gradients. J. Virol. Meth. 31:1991;161-170.
18. Niwa H.K.Y., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 108:1991;193-200.
19. Olmsted R.A., Collins P.L. The 1A protein of respiratory syncytial virus is an integral membrane protein present as multiple, structurally distinct species. J. Virol. 63:1989;2019-2029.
20. Olmsted R.A., Elango N., Prince G.A., Murphy B.R., Johnson P.R., Moss B., Chanock R.M., Collins P.L. Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proc. Natl. Acad. Sci. USA. 83:1986;7462-7466.
21. Perez M., Watanabe M., Whitt M.A., Carlos de la Torre J. N-terminal domain of borna disease virus G (p56) protein is sufficient for virus receptor recognition and cell entry. J. Virol. 75:2001;7078-7085.
22. Roberts S.R., Compans R.W., Wertz G.W. Respiratory syncytial virus buds from the apical surfaces of polarized epithelial cells. J. Virol. 69:1995;2667-2673.
23. Roberts A., Kretzschmar E., Perkins A.S., Forman J., Price R., Buonocore L., Kawaoka Y., Rose J.K. Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge. J. Virol. 72:1998;4704-4711.
24. Roberts A., Buonocore L., Price R., Forman J., Rose J.K. Attenuated vesicular stomatitis viruses as vaccine vectors. J. Virol. 73:1999;3723-3732.
25. Spriggs M.K., Olmstead R.A., Venkatesan S., Coligan J.E., Collins P.L. Fusion protein of human parainfluenza virus type 3: nucleotide sequence of the gene, direct identification of the cleavage activation site, and comparison with other paramyxoviruses. Virology. 152:1986;241-251.
26. Takada A., Robison C., Goto H., Sanchez A., Murti K.G., Whitt M.A., Kawaoka Y. A system for functional analysis of Ebola virus glycoprotein. Proc. Natl. Acad. Sci. USA. 94:1997;14764-14769.
27. Tatsuo H., Okuma K., Tanaka K., Ono N., Minagawa H., Takade A., Matsuura Y., Yanagi Y. Virus entry is a major determinant of cell tropism of Edmonton and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteins. J. Virol. 74:2000;4139-4145.
28. Techaarpornkul S., Barretto N., Peeples M.E. Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment protein. J. Virol. 75:2001;6825-6834.
29. Walsh E.E., Hruska J. Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein. J. Virol. 47:1983;171-177.
30. Watanabe S., Takada A., Watanabe T., Ito H., Hiroshi K., Kawaoka Y. Functional importance of the coiled-coil of the Ebola virus glycoprotein. J. Virol. 74:2000;10194-10201.
31. Wool-Lewis R.J., Bates P. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J. Virol. 72:1998;3155-3160.